AI-POWERED GENOMIC SIGNAL DETECTION
Detect Cancer Earlier When It's Most Curable
EarlySignal Diagnostics is developing a blood test that uses Al and advanced genomics to detect multiple cancers before symptoms appear-when treatment can save lives.
Simple Blood Test
A single blood draw to detect multiple cancers early.
Al-Powered Analysis
Machine learning designed to detect subtle genomic signals in cell-free DNA
Multi-Cancer Detection
Designed to detect a wide range of cancers before symptoms arise.
Earlier. Actionable. Better.
Enabling earlier interventions and better outcomes when it matters most.
ABOUT EARLYSIGNAL
Revolutionizing Early
Cancer Detection
EarlySignal Diagnostics is developing a next-generation blood test that combines Al with genomic and epigenomic biomarkers to detect cancer at the earliest stage-before symptoms appear and when treatment can be most effective. Our mission is to transform cancer detection and improve survival through earlier, smarter, and more accessible testing.
THE GAP WE AIM TO CLOSE
Most Cancers Are Found Too Late
Late-Stage Diagnosis
Many cancers are diagnosed after the disease has advanced.
Earlier Detection Matters
Finding cancer earlier may expand opportunities for timely care.
One Simple Test
EarlySignal is developing a blood test to support earlier cancer detection.
OUR TECHNOLOGY
Al + Genomics.
The Power to Detect Earlier.
We combine Al with methylation-based multi-omics to detect subtle genomic signals shed by tumors into the bloodstream-long before symptoms appear.
Methylation Biomarkers
Methylation biomarkers in cell-free DNA
Multi-Omics Integration
Combining methylation data with other omics for deeper insights.
Al & Machine Learning
Algorithms designed to find patterns in complex genomic data
Early Signal Detection
Detecting the earliest signals of cancer for eariler intervention.
1. Blood Draw
A simple blood sample is collected.
2. Genomic Analysis
We analyze cell-free DNA and methylation pattens.
3. Al Interpretation
AI models are being developed to identify cancer signals in cell-free DNA
4. Actionable Insight
Cinicians receive insights for earlier decisions.
OUR RESEARCH
Built on Science
Backed by Research
Our Test is in development and clinical validation. We are conducting rigorous studies to ensure accuracy, reliability, and real world impact.
In Development
Our test is currently in research and clinical validation.
Clinical Studies
Ongoing stooles to validate accuracy across multiple cancer types.
Future Impact
Our goal is to make early cancer detection a new standard in core.
CATS TONOMETER
Advanced IOP Measurement
for Better Eye Care
Our CATS Tonometer provides accurate, reliable, and patient-friendly intraocular pressure measurements to help eye care professionals make better clinical decisions
Join Us in Detecting Cancer Earlier
Partner with EartySignal Diagnostics to change the future of cancer detection.